𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma

✍ Scribed by Robert J. Biggar; Michael Christiansen; Klaus Rostgaard; Karin Ekström Smedby; Hans-Olov Adami; Bengt Glimelius; Henrik Hjalgrim; Mads Melbye


Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
145 KB
Volume
124
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Allergy/atopy has been suggested to protect against non‐Hodgkin lymphoma (NHL) and specific IgE levels are decreased in patients with NHL. We speculated that all immunoglobulin subclass levels might be downregulated in NHL and examined levels of IgM, IgD, IgA, IgE, IgG and IgG~4~ in 200 NHL patients and 200 age‐ and sex‐matched controls. Patients with B‐cell NHL of many types had consistently lower median immunoglobulin subclass levels than controls. In every subclass except IgD, about 10–15% of B‐cell NHL patients had absolute levels below the 2.5 percentile of controls. Subclass levels correlated with each other and many patients had more than one significantly low level. Levels were lowest for IgG~4~ and IgE. Patients with chronic lymphocytic leukemia/small lymphocytic lymphoma had especially low total IgE levels. In other B‐cell NHL types, total IgE levels were decreased to a similar extent as other immunoglobulin subclasses. In conclusion, low IgE levels are only part of a more generalized loss of immunoglobulins of all subtypes in a wide variety of B‐cell NHL types. Low immunoglobulin levels appear to be a consequence of B‐cell NHL presence, and we speculate about molecular mechanisms that could reduce all immunoglobulin subclasses in B‐cell NHL. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Hodgkin disease with subsequent transfor
✍ Naoyoshi Mori; Kazuko Watanabe; Yoriko Yamashita; Atsuo Nakayama; Yasushi Yatabe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

## Background: Previous studies have indicated that some patients with hodgkin disease have an aggressive clinical course. however, their characteristics have not been elucidated. ## Methods: Six patients initially diagnosed as having hodgkin disease with subsequent transformation to cd30 positiv

Causes of death in patients with non-Hod
✍ Stanley Ostrow; Charles H. Diggs; John Sutherland; Peter H. Wiernik 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

The causes of death and postmortem findings in patients treated for non-Hodgkin's lymphoma at a single institution over a 13-year period were reviewed. Postmortem examination (70% of the entire sample) revealed evidence of lymphoma in 67 of 80 patients. The most frequent extranodal sites of involvem

Second malignant neoplasms in patients w
✍ Dr Michael Lishner; Joyce Slingerland; Joseph Barr; Tony Panzarella; Pam Degendo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 715 KB

## Abstract A retrospective review of the records of 3886 patients with non‐Hodgkin's lymphoma registered at the Princess Margaret Hospital between 1970 and 1985 was undertaken to determine the incidence of second malignant tumours. Three thousand and twenty‐one patients with a minimum documented f